Ortho-McNeil Janssen Scientific Affairs

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Ortho-McNeil Janssen Scientific Affairs sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 6 completed later-stage tilt upper quartile by trial count

Ortho-McNeil Janssen Scientific Affairs: 7 sponsored US clinical trials, none currently recruiting.

Ortho-McNeil Janssen Scientific Affairs sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 7 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Back Pain, with 1 trials.

Upper-quartile sponsor footprint

Ortho-McNeil Janssen Scientific Affairs sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

COMPLETED Phase 3

Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement

NCT01094886
COMPLETED Phase 3

NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain

NCT00986180
TERMINATED Phase 4

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

NCT00946985
COMPLETED Phase 4

CONCERTA Lab School Study

NCT00799487
COMPLETED Phase 4

Lab School Day Study for CONCERTA of Older Children With ADHD

NCT00799409
COMPLETED Phase 3

Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis

NCT00771758
COMPLETED Phase 4

Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease

NCT00535145

Phase Distribution

PhaseTrial count
Phase 3 3
Phase 4 4

Therapeutic Areas

Back Pain 1

How the Ortho-McNeil Janssen Scientific Affairs archive is shaped

7 indexed studies, none listed as recruiting (0% open); 6 completed (86%).

Phase mix: 7 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Back Pain (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Ortho-McNeil Janssen Scientific Affairs: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Ortho-McNeil Janssen Scientific Affairs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Ortho-McNeil Janssen Scientific Affairs3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
Ortho-McNeil Janssen Scientific Affairs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ortho-McNeil Janssen Scientific Affairs sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Ortho-McNeil Janssen Scientific Affairs page

7 registered trials is a research-attention snapshot, not an endorsement of Ortho-McNeil Janssen Scientific Affairs or any single study.

  • None of Ortho-McNeil Janssen Scientific Affairs's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Back Pain is the condition Ortho-McNeil Janssen Scientific Affairs studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Back Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ortho-McNeil Janssen Scientific Affairs pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.